| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | glial cell proliferation | 8.55e-05 | 87 | 55 | 4 | GO:0014009 | |
| GeneOntologyBiologicalProcess | macrophage colony-stimulating factor signaling pathway | 1.45e-04 | 7 | 55 | 2 | GO:0038145 | |
| GeneOntologyBiologicalProcess | cellular component maintenance | 1.52e-04 | 101 | 55 | 4 | GO:0043954 | |
| GeneOntologyBiologicalProcess | establishment of skin barrier | 1.78e-04 | 41 | 55 | 3 | GO:0061436 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 1.81e-04 | 313 | 55 | 6 | GO:0099173 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 1.93e-04 | 8 | 55 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | positive regulation of osteoclast differentiation | 2.20e-04 | 44 | 55 | 3 | GO:0045672 | |
| GeneOntologyBiologicalProcess | cell junction organization | 2.22e-04 | 974 | 55 | 10 | GO:0034330 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte activation | 2.48e-04 | 9 | 55 | 2 | GO:0061888 | |
| GeneOntologyBiologicalProcess | microglial cell proliferation | 2.48e-04 | 9 | 55 | 2 | GO:0061518 | |
| GeneOntologyBiologicalProcess | dendritic spine organization | 2.51e-04 | 115 | 55 | 4 | GO:0097061 | |
| GeneOntologyBiologicalProcess | astrocyte development | 2.68e-04 | 47 | 55 | 3 | GO:0014002 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 3.10e-04 | 10 | 55 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 3.10e-04 | 10 | 55 | 2 | GO:0072015 | |
| GeneOntologyCellularComponent | laminin-3 complex | 2.04e-05 | 3 | 55 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | cell surface | CD1D LRFN1 STAB2 CSF1R ADGRG2 KCNJ3 CD34 TREM2 LRP4 TNFRSF11A CTNND1 TMPRSS11F | 2.51e-05 | 1111 | 55 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | keratohyalin granule | 6.76e-05 | 5 | 55 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | laminin complex | 3.02e-04 | 10 | 55 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 9.01e-04 | 17 | 55 | 2 | GO:0098637 | |
| HumanPheno | Triceps weakness | 1.32e-06 | 18 | 25 | 4 | HP:0031108 | |
| HumanPheno | Proximal muscle weakness in upper limbs | 1.58e-05 | 68 | 25 | 5 | HP:0008997 | |
| Domain | EGF_Lam | 7.48e-10 | 35 | 55 | 6 | SM00180 | |
| Domain | Laminin_EGF | 1.26e-09 | 38 | 55 | 6 | IPR002049 | |
| Domain | EGF | 2.61e-08 | 235 | 55 | 9 | SM00181 | |
| Domain | EGF-like_dom | 4.29e-08 | 249 | 55 | 9 | IPR000742 | |
| Domain | EGF_1 | 5.26e-08 | 255 | 55 | 9 | PS00022 | |
| Domain | Laminin_EGF | 5.58e-08 | 35 | 55 | 5 | PF00053 | |
| Domain | EGF-like_CS | 6.42e-08 | 261 | 55 | 9 | IPR013032 | |
| Domain | EGF_2 | 7.32e-08 | 265 | 55 | 9 | PS01186 | |
| Domain | EGF_LAM_2 | 1.74e-06 | 30 | 55 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.74e-06 | 30 | 55 | 4 | PS01248 | |
| Domain | Growth_fac_rcpt_ | 6.38e-06 | 156 | 55 | 6 | IPR009030 | |
| Domain | Laminin_N | 1.32e-05 | 16 | 55 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 1.32e-05 | 16 | 55 | 3 | PS51117 | |
| Domain | Laminin_N | 1.32e-05 | 16 | 55 | 3 | PF00055 | |
| Domain | LamNT | 1.32e-05 | 16 | 55 | 3 | SM00136 | |
| Domain | EGF_CA | 2.93e-05 | 122 | 55 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.17e-05 | 124 | 55 | 5 | IPR001881 | |
| Domain | EGF | 3.43e-05 | 126 | 55 | 5 | PF00008 | |
| Domain | EGF_3 | 6.45e-05 | 235 | 55 | 6 | PS50026 | |
| Domain | hEGF | 7.51e-05 | 28 | 55 | 3 | PF12661 | |
| Domain | Laminin_aI | 8.47e-05 | 5 | 55 | 2 | IPR009254 | |
| Domain | Laminin_I | 8.47e-05 | 5 | 55 | 2 | PF06008 | |
| Domain | Laminin_II | 8.47e-05 | 5 | 55 | 2 | PF06009 | |
| Domain | Laminin_domII | 8.47e-05 | 5 | 55 | 2 | IPR010307 | |
| Domain | EGF_Ca-bd_CS | 1.90e-04 | 97 | 55 | 4 | IPR018097 | |
| Domain | EGF_CA | 2.06e-04 | 99 | 55 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.14e-04 | 100 | 55 | 4 | PS00010 | |
| Domain | LAMININ_IVA | 2.36e-04 | 8 | 55 | 2 | PS51115 | |
| Domain | Laminin_B | 2.36e-04 | 8 | 55 | 2 | PF00052 | |
| Domain | LamB | 2.36e-04 | 8 | 55 | 2 | SM00281 | |
| Domain | Laminin_IV | 2.36e-04 | 8 | 55 | 2 | IPR000034 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.68e-04 | 106 | 55 | 4 | IPR000152 | |
| Domain | EGF_extracell | 7.34e-04 | 60 | 55 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.34e-04 | 60 | 55 | 3 | PF07974 | |
| Domain | EMI_domain | 9.95e-04 | 16 | 55 | 2 | IPR011489 | |
| Domain | EMI | 1.13e-03 | 17 | 55 | 2 | PS51041 | |
| Domain | EGF_CA | 2.08e-03 | 86 | 55 | 3 | PF07645 | |
| Domain | S100_CABP | 2.85e-03 | 27 | 55 | 2 | PS00303 | |
| Domain | S_100 | 2.85e-03 | 27 | 55 | 2 | PF01023 | |
| Domain | S100_Ca-bd_sub | 3.06e-03 | 28 | 55 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 3.06e-03 | 28 | 55 | 2 | IPR001751 | |
| Domain | S_100 | 3.06e-03 | 28 | 55 | 2 | SM01394 | |
| Domain | - | 3.18e-03 | 663 | 55 | 7 | 2.60.40.10 | |
| Domain | Ig_E-set | 3.57e-03 | 104 | 55 | 3 | IPR014756 | |
| Domain | Ig-like_fold | 4.49e-03 | 706 | 55 | 7 | IPR013783 | |
| Domain | LAM_G_DOMAIN | 5.59e-03 | 38 | 55 | 2 | PS50025 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.60e-06 | 11 | 44 | 3 | M158 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 8.99e-05 | 76 | 44 | 4 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.09e-04 | 30 | 44 | 3 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.09e-04 | 30 | 44 | 3 | M27216 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.45e-04 | 33 | 44 | 3 | M39503 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 2.78e-04 | 41 | 44 | 3 | M27778 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.92e-04 | 46 | 44 | 3 | M239 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.38e-07 | 7 | 56 | 3 | 9004048 | |
| Pubmed | 4.71e-07 | 10 | 56 | 3 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 6.46e-07 | 11 | 56 | 3 | 21524702 | |
| Pubmed | 8.61e-07 | 12 | 56 | 3 | 9396756 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX2 SPHK2 LRFN1 MEGF6 CTC1 LRP4 MFN2 LAMB2 TANC1 MED13L PRAG1 | 1.27e-06 | 1105 | 56 | 11 | 35748872 |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.77e-06 | 15 | 56 | 3 | 15895400 | |
| Pubmed | 2.18e-06 | 16 | 56 | 3 | 17601529 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 8939648 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 33841415 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 23116709 | ||
| Pubmed | 3.17e-06 | 18 | 56 | 3 | 11311202 | ||
| Pubmed | 4.42e-06 | 20 | 56 | 3 | 22911573 | ||
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 21930791 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 7.63e-06 | 3 | 56 | 2 | 23403047 | |
| Pubmed | 7.63e-06 | 3 | 56 | 2 | 17426950 | ||
| Pubmed | 1.00e-05 | 26 | 56 | 3 | 24742657 | ||
| Pubmed | 1.40e-05 | 29 | 56 | 3 | 22613833 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 26926447 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 8081888 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 2099832 | ||
| Pubmed | The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. | 1.52e-05 | 4 | 56 | 2 | 15750601 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PCNX2 PDE3B SGSM1 MEGF6 KCNJ3 LAMA3 TANC1 CTNND1 CAMTA1 ZNF107 ADSS1 | 2.15e-05 | 1489 | 56 | 11 | 28611215 |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 11969289 | ||
| Pubmed | Developmental origin, functional maintenance and genetic rescue of osteoclasts. | 2.54e-05 | 5 | 56 | 2 | 30971820 | |
| Pubmed | Differential expression of five laminin alpha (1-5) chains in developing and adult mouse kidney. | 2.54e-05 | 5 | 56 | 2 | 9415429 | |
| Pubmed | Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. | 2.54e-05 | 5 | 56 | 2 | 11369940 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 11829758 | ||
| Pubmed | Differential expression of laminin alpha chains during murine tooth development. | 2.54e-05 | 5 | 56 | 2 | 9389447 | |
| Pubmed | 3.74e-05 | 40 | 56 | 3 | 27068110 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 3.80e-05 | 6 | 56 | 2 | 23948589 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 3.80e-05 | 6 | 56 | 2 | 18817539 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 2119632 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 9597096 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 26555376 | ||
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 31091440 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 3.80e-05 | 6 | 56 | 2 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 3.80e-05 | 6 | 56 | 2 | 3109910 | |
| Pubmed | 4.04e-05 | 118 | 56 | 4 | 30979931 | ||
| Pubmed | Proteome-wide analysis of phospho-regulated PDZ domain interactions. | 4.34e-05 | 42 | 56 | 3 | 30126976 | |
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 7921537 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 30538245 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 14557481 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 23478294 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 9852162 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 8872465 | ||
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 9693030 | ||
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 9.10e-05 | 9 | 56 | 2 | 19295126 | |
| Pubmed | 9.10e-05 | 9 | 56 | 2 | 12122015 | ||
| Pubmed | Analysis of recently identified osteoporosis susceptibility genes in Han Chinese women. | 1.14e-04 | 10 | 56 | 2 | 20554715 | |
| Pubmed | 1.30e-04 | 486 | 56 | 6 | 20936779 | ||
| Pubmed | Suppression of Notch signalling by the COUP-TFII transcription factor regulates vein identity. | 1.39e-04 | 11 | 56 | 2 | 15875024 | |
| Pubmed | Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. | 1.39e-04 | 11 | 56 | 2 | 11435469 | |
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 12051813 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 1.39e-04 | 11 | 56 | 2 | 23472759 | |
| Pubmed | 1.61e-04 | 65 | 56 | 3 | 32120844 | ||
| Pubmed | 1.66e-04 | 12 | 56 | 2 | 26794322 | ||
| Pubmed | 1.66e-04 | 12 | 56 | 2 | 16750824 | ||
| Pubmed | 1.85e-04 | 175 | 56 | 4 | 28071719 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 15673434 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 36350252 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 37704707 | ||
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 16212419 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 1.96e-04 | 13 | 56 | 2 | 21900571 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 2.20e-04 | 536 | 56 | 6 | 15840001 | |
| Pubmed | 2.25e-04 | 538 | 56 | 6 | 10512203 | ||
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 19079262 | ||
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 9151674 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 2.64e-04 | 15 | 56 | 2 | 12921739 | |
| Pubmed | 2.64e-04 | 15 | 56 | 2 | 9264260 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.87e-04 | 79 | 56 | 3 | 18757743 | |
| Pubmed | 3.01e-04 | 16 | 56 | 2 | 31823782 | ||
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 3.01e-04 | 16 | 56 | 2 | 17948866 | |
| Pubmed | Local network topology in human protein interaction data predicts functional association. | 3.01e-04 | 16 | 56 | 2 | 19641626 | |
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 3.41e-04 | 17 | 56 | 2 | 15056720 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 4.27e-04 | 218 | 56 | 4 | 33378226 | |
| Pubmed | 4.75e-04 | 20 | 56 | 2 | 21750040 | ||
| Pubmed | 4.81e-04 | 225 | 56 | 4 | 12168954 | ||
| Pubmed | Variation in genes of the epidermal differentiation complex in German atopic dermatitis patients. | 5.24e-04 | 21 | 56 | 2 | 19601998 | |
| Pubmed | 5.24e-04 | 21 | 56 | 2 | 8499630 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 5.24e-04 | 21 | 56 | 2 | 25249183 | |
| Pubmed | Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. | 5.76e-04 | 22 | 56 | 2 | 9324354 | |
| Pubmed | Sox4 links tumor suppression to accelerated aging in mice by modulating stem cell activation. | 6.87e-04 | 24 | 56 | 2 | 25043184 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.80e-04 | 256 | 56 | 4 | 33397691 | |
| Pubmed | 8.07e-04 | 26 | 56 | 2 | 20301347 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 8.07e-04 | 26 | 56 | 2 | 34189436 | |
| Pubmed | 8.69e-04 | 963 | 56 | 7 | 28671696 | ||
| Pubmed | 9.98e-04 | 1285 | 56 | 8 | 35914814 | ||
| Pubmed | 1.01e-03 | 29 | 56 | 2 | 30220628 | ||
| Pubmed | The insulin receptor substrate of 53 kDa (IRSp53) limits hippocampal synaptic plasticity. | 1.01e-03 | 29 | 56 | 2 | 19208628 | |
| Pubmed | Sox11 gene disruption causes congenital anomalies of the kidney and urinary tract (CAKUT). | 1.15e-03 | 31 | 56 | 2 | 29459093 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.16e-03 | 736 | 56 | 6 | 29676528 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 1.28e-03 | 132 | 56 | 3 | 16944949 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | 1.29e-03 | 1031 | 56 | 7 | 16710414 | |
| Pubmed | 1.38e-03 | 34 | 56 | 2 | 32553152 | ||
| GeneFamily | Laminin subunits | 1.44e-06 | 12 | 35 | 3 | 626 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 7.60e-05 | 7 | 35 | 2 | 1350 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 9.08e-04 | 394 | 35 | 5 | 471 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 5.75e-09 | 199 | 56 | 7 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.52e-07 | 192 | 56 | 6 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-07 | 193 | 56 | 6 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.61e-07 | 194 | 56 | 6 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-07 | 200 | 56 | 6 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.93e-07 | 200 | 56 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.93e-07 | 200 | 56 | 6 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.93e-07 | 200 | 56 | 6 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-06 | 150 | 56 | 5 | b37f538ca5f976b509efe35dc81115b72b227084 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-06 | 150 | 56 | 5 | 2c7518918c40e1bf679a2d4e83b472ee6f2f9df8 | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.61e-06 | 157 | 56 | 5 | e9d0300361b06aec3c216f8af15f09e14b12a4da | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-06 | 157 | 56 | 5 | b9d04ee417c0d8ea0801d10f1c54e138587009fd | |
| ToppCell | PBMC-Severe-Myeloid-cDC-cDC-cDC_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-06 | 158 | 56 | 5 | e9657d8960d499832f9f9b45b5a6f4388551b7e1 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.87e-06 | 162 | 56 | 5 | 2787be283b7a705647058aeb9bc54006ce5ffe95 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.24e-06 | 168 | 56 | 5 | 3d8c431a3c8899383212fe6a7627889c40c5f3ef | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 170 | 56 | 5 | 03cb4e508356f85372a588c8d1c6babf2a012683 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-06 | 170 | 56 | 5 | 8d3c51364a332020810836e2055c60893c10d7f3 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 171 | 56 | 5 | 9498c35b2a2c3a339dc8c5d49c8ec20d8ad52753 | |
| ToppCell | droplet-Spleen-nan-21m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 171 | 56 | 5 | db544252f98e073e5bb4bec4a110cd58e6434435 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.51e-06 | 172 | 56 | 5 | f0e767a20d93e546ce278db67dbd779cc68af533 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.66e-06 | 174 | 56 | 5 | f520b79d277e286c9bb5d091e6c94e7ec7e46699 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 176 | 56 | 5 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 176 | 56 | 5 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 176 | 56 | 5 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-06 | 177 | 56 | 5 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-06 | 177 | 56 | 5 | 5f20a1a875d6f85ec07b097e6afdb07c2f8f88ff | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 182 | 56 | 5 | 2cc434e46985c66fc36de05344a67aa96d90abc9 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 182 | 56 | 5 | 0cde2775bdaaa2172499925bd59b0ac2d545eb27 | |
| ToppCell | facs-Lung-24m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 182 | 56 | 5 | 3e7457b2a70b45735fb75d6617b7f34cef28758e | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.40e-06 | 183 | 56 | 5 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 3.78e-06 | 187 | 56 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Lobular_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 3.88e-06 | 188 | 56 | 5 | c90669b51e1902fe7726555290c91c92a911df83 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-06 | 190 | 56 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-06 | 191 | 56 | 5 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.19e-06 | 191 | 56 | 5 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.30e-06 | 192 | 56 | 5 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.41e-06 | 193 | 56 | 5 | 2f203f6f0c2135acb046c9351a633c3b5b254a46 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.52e-06 | 194 | 56 | 5 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.52e-06 | 194 | 56 | 5 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.52e-06 | 194 | 56 | 5 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.52e-06 | 194 | 56 | 5 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.64e-06 | 195 | 56 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | ASK454-Endothelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.75e-06 | 196 | 56 | 5 | 14dd6956ef420b660be0baf52a66960e57d75d16 | |
| ToppCell | (4)_Endothelial_cells-(41)_EC-arteriolar|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 4.87e-06 | 197 | 56 | 5 | 482e3f8926880afed88ed37553ed2b5ed58b8c99 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.12e-06 | 199 | 56 | 5 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 5.25e-06 | 200 | 56 | 5 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.81e-05 | 124 | 56 | 4 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.91e-05 | 140 | 56 | 4 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 143 | 56 | 4 | 4d11d53330a9197275a8851e1bbf55a113715a09 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.16e-05 | 143 | 56 | 4 | 8b9f4d87d5faac7752c83e1992491fc5550600f8 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.43e-05 | 146 | 56 | 4 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.22e-05 | 154 | 56 | 4 | 79ebda35dd1719e157738d7c13e5b8ccc3991f03 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.44e-05 | 156 | 56 | 4 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.44e-05 | 156 | 56 | 4 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | ec433d2fe827abdb647be4176c231b7052482b6f | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | 0966e347f8d32b13f8a3b3afba3f64637c69cdf9 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 157 | 56 | 4 | 6ebfedd91d62c6d4aa8f046657a899a279f82ba2 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 158 | 56 | 4 | b35bab2b93d0af821bfae18a358eb7dddaf3860f | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.66e-05 | 158 | 56 | 4 | 7bd4a64a610eb1cbcd3d07ea5258a55107cf6c00 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.78e-05 | 159 | 56 | 4 | c0e55f25271f788c08fa4b95186501fc27b2ec39 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.02e-05 | 161 | 56 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | droplet-Fat-Gat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 162 | 56 | 4 | 052f797d8bcab8fc6a43e0bffdd215c88ee12889 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 162 | 56 | 4 | 373513f9d0e5007b2e10a8b78d4909dcce9e3b62 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 163 | 56 | 4 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 5.27e-05 | 163 | 56 | 4 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.27e-05 | 163 | 56 | 4 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 164 | 56 | 4 | cd0794f84dfd346807e2d803723718b7f22e9232 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.39e-05 | 164 | 56 | 4 | 12251a49fd4af32d4edb58046245548c260cf04b | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | be7e18d798e81e4b0f3080054aa222c6913e350b | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 518ee34c18065100a2f2c6e407d3a7866b908593 | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.52e-05 | 165 | 56 | 4 | 8d3d5860a4785c4908160ae5fcb421ee80bd78ce | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | becb8f726b84509ec29c75b530a3fe757651301d | |
| ToppCell | E15.5-Endothelial-lymphatic_endothelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.52e-05 | 165 | 56 | 4 | 17ee6f269ed8d378465cf00ca59d48d8b106808e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | ae8dd9c00f96590f27ed21cd6314f4577e00e312 | |
| ToppCell | facs-Heart-LA-18m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.52e-05 | 165 | 56 | 4 | 941a5b95164eaea47c3e6376e358f94c15b98312 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 166 | 56 | 4 | 006ced12f69ef13ddcba5a3891ddc7c18c384863 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-05 | 166 | 56 | 4 | ac28c8cac1e94be0c47fb862c5809c92cdaa11f3 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.65e-05 | 166 | 56 | 4 | f416d8a322f086c769659a9fab6b460a2d546ab1 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.65e-05 | 166 | 56 | 4 | 6bb3410e65c971acc458c472015afcec6de6e310 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM5|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.65e-05 | 166 | 56 | 4 | 823ec03714884cb860a1260410feac8c536b6d06 | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-myeloid_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | 5d9ffbcb539d9c50cef9dd792ea11aa37dd2c1df | |
| ToppCell | facs-GAT-Fat-24m-Myeloid|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | c31e41fb76ba261ac546fac3cc2b8337e39bfa86 | |
| ToppCell | droplet-Heart-nan-3m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | 47447bcf184b1ad24ef17e135199fe7cd1d73c02 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.79e-05 | 167 | 56 | 4 | d62d5dec30d006a9cc8f3bc5ccc578e10f105027 | |
| ToppCell | facs-GAT-Fat-24m-Myeloid-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.79e-05 | 167 | 56 | 4 | a04d1f2413fd24ad5e9cc67312220606157fecf3 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | d72cd8238fa793bb3e4add4c59eaaaadcea9930d | |
| ToppCell | droplet-Fat-Scat-18m-Myeloid-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | 749eccebe4ee066f827d2a3980512f195f23ac27 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | 95416f352801ce42cc317565e7dfb00478c593e1 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-05 | 168 | 56 | 4 | ba9ddd403ee6d6af2fe56dffbd419764bfb703e4 | |
| ToppCell | facs-Heart-RV-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | 8ee57814c7e9d45444f48b6b269c4d535bc4d5e1 | |
| ToppCell | facs-Thymus-nan-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | c34c52165485f612add7a3e35a175d5a6e365e7c | |
| Drug | AC1L1G72 | 2.29e-06 | 11 | 56 | 3 | CID000003553 | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 8.56e-06 | 196 | 56 | 6 | 2229_DN | |
| Drug | Isosorbide dinitrate [87-33-2]; Up 200; 17uM; PC3; HT_HG-U133A | 8.56e-06 | 196 | 56 | 6 | 3720_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 8.81e-06 | 197 | 56 | 6 | 6947_UP | |
| Drug | AC1L1B58 | 4.92e-05 | 29 | 56 | 3 | CID000001288 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 5.22e-05 | 83 | 56 | 4 | CID011968896 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.01e-04 | 189 | 56 | 5 | 1005_DN | |
| Drug | 15(S)-15-methyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 192 | 56 | 5 | 7489_UP | |
| Drug | Ambroxol hydrochloride [23828-92-4]; Down 200; 9.6uM; HL60; HG-U133A | 1.09e-04 | 192 | 56 | 5 | 1623_DN | |
| Drug | Pimozide [2062-78-4]; Up 200; 8.6uM; HL60; HG-U133A | 1.09e-04 | 192 | 56 | 5 | 1562_UP | |
| Drug | Oxalamine citrate salt [1949-20-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 3344_UP | |
| Drug | Calcort | 1.12e-04 | 38 | 56 | 3 | CID000026709 | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 1.17e-04 | 195 | 56 | 5 | 6245_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.20e-04 | 196 | 56 | 5 | 5540_DN | |
| Drug | Nizatidine [76963-41-2]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3385_UP | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 2228_DN | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 5482_DN | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 5943_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 6790_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 5996_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 5425_UP | |
| Drug | Josamycin [16846-24-5]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 1534_DN | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 2822_UP | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 5906_DN | |
| Drug | Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.29e-04 | 199 | 56 | 5 | 5542_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 56 | 5 | 5299_DN | |
| Disease | bone development disease (implicated_via_orthology) | 3.54e-06 | 2 | 56 | 2 | DOID:0080006 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of salivary gland | 8.68e-05 | 45 | 56 | 3 | C0220636 | |
| Disease | Salivary Gland Neoplasms | 9.89e-05 | 47 | 56 | 3 | C0036095 | |
| Disease | cortical thickness | 2.30e-04 | 1113 | 56 | 9 | EFO_0004840 | |
| Disease | Charcot-Marie-Tooth disease (is_implicated_in) | 2.31e-04 | 12 | 56 | 2 | DOID:10595 (is_implicated_in) | |
| Disease | Dementia | 4.72e-04 | 17 | 56 | 2 | C0497327 | |
| Disease | Adenoid Cystic Carcinoma | 9.19e-04 | 100 | 56 | 3 | C0010606 | |
| Disease | Myasthenic Syndromes, Congenital | 9.51e-04 | 24 | 56 | 2 | C0751882 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QGICNSSNHVQNGVT | 211 | P59817 | |
| NGGSQAQCASGTGAL | 1016 | Q9Y6Y1 | |
| LQGGQSPFQATASCH | 1016 | Q2NKJ3 | |
| NNDCSVHASGNGNAS | 946 | Q8IZP9 | |
| VHASGNGNASTERNG | 951 | Q8IZP9 | |
| AQTIGNSGSANGIHQ | 1021 | Q9UDT6 | |
| SACSQPHGSVTQSQG | 16 | O96017 | |
| GCHTSFTGQGTNASE | 831 | O14917 | |
| AATNGCTGDANGHLQ | 536 | Q9NPH2 | |
| GNIGFDCHLNGTASQ | 76 | Q9H3L0 | |
| SSCQSHRFGGQGNQF | 296 | Q5D862 | |
| VCGSGQTCGQHESTS | 446 | Q5D862 | |
| QSVASAGGHIAVGQQ | 296 | Q71F56 | |
| QSSGQVHAFGNCSDS | 16 | Q7Z3D4 | |
| GHSNQCQDGSGICVN | 1691 | Q16787 | |
| HVCSQTNGAGTGAAQ | 581 | Q9P244 | |
| GAQHGVSSCEGTQRT | 1916 | A6NKB5 | |
| QQIHNGCGTGNETDS | 761 | Q13370 | |
| STHSCQNGGVFQTPQ | 231 | Q5VY43 | |
| HFCSQGQHGSTSGQS | 1306 | Q86YZ3 | |
| HFCSQGQHGSTSGQS | 1776 | Q86YZ3 | |
| HFCSQGQHGSTSGQS | 2246 | Q86YZ3 | |
| HFCSQGQHGSTSGQS | 2716 | Q86YZ3 | |
| GGNSHIANGAAGCVA | 166 | Q96A46 | |
| QGTLCGTGNRNSGSQ | 141 | Q96EZ4 | |
| SGNVSGGVCDGCQHN | 366 | P55268 | |
| NAGGSFSEVCHSQTG | 921 | P24043 | |
| GSNCSHQVQQELSGT | 681 | O95140 | |
| HGNGAASVTAQARGQ | 101 | Q9BZJ0 | |
| QHAGNYSCVASNVQG | 271 | P07333 | |
| VSAGCEVHPGNASNN | 116 | P15813 | |
| LGNGSQVTQAANSGC | 546 | Q86V48 | |
| ENGTGQATSRNGHSA | 361 | P28906 | |
| LTNFSCHGKNGTTNG | 446 | Q9ULM6 | |
| NVANNTGPHAASCFG | 606 | O60716 | |
| NNCSHGGTCQDLVNG | 381 | P78504 | |
| IVNSCEANNGGCSHG | 331 | O75095 | |
| AQGNGHCVNGISGQV | 231 | Q9UQC2 | |
| QSAHSASEQQLGGGA | 371 | P35716 | |
| VAAGSAGHCDGQQAL | 546 | Q8IYL2 | |
| SRCQGGNNAGHTVVV | 61 | Q8N142 | |
| GQFVNGTSQVHSECG | 206 | Q6UWF7 | |
| TSQHLGSGQSAVRNG | 1536 | Q9C0D5 | |
| QNGGTCTHGINSFRC | 321 | Q8TER0 | |
| GAQNASGNTALHICA | 341 | Q9Y566 | |
| GCTGRGHVNSNRNTH | 416 | O60284 | |
| VQFGHAGACANQASE | 756 | P53396 | |
| GHKGGHNTVNQCLTA | 56 | Q9UII5 | |
| NVQSCGTNSHGILSG | 256 | Q9H1C4 | |
| QASLQLIGSGHQCGA | 221 | Q6ZWK6 | |
| CGSGNALAGAVNQHG | 276 | Q9NRA0 | |
| GTHTCVCQQGWTGNG | 891 | Q8WWQ8 | |
| QSGSADGSSTNGCNH | 516 | Q2NKQ1 | |
| AAAAQGQGQVCTGNA | 436 | Q86YV5 | |
| SGAHNTTVFQGVAGQ | 16 | Q9NZC2 | |
| HCGTGTAAGQEQATG | 871 | Q9P2E3 | |
| NDILQHQGSNCGGTS | 61 | Q9NUQ3 | |
| HQGSNCGGTSNKHSL | 66 | Q9NUQ3 | |
| SVHVGQAGVQIGNAC | 6 | Q9NY65 | |
| THTANFGQQGACEGV | 271 | Q9Y6Q6 | |
| GRCNVQHGNLGSETS | 51 | P48549 | |
| QTGTNACGVNNGGCT | 1611 | O75096 |